Translating physiology of the arterial chemoreflex into novel therapeutic interventions targeting carotid bodies in cardiometabolic disorders
Open Access
- 5 April 2025
- journal article
- review article
- Published by Wiley in The Journal of Physiology
- Vol. 603 (9) , 2487-2516
Abstract
This review resulted from a conference on the pathological role of arterial chemoreflex and carotid bodies in cardiometabolic diseases held at the 27th Congress of the Polish Cardiac Society in September 2023 in Poznan, Poland. It reflects the contribution of Polish researchers and their international collaborations, which have been fundamental in the development of the field. Aberrant activity of the carotid bodies leads to both high tonicity and increased sensitivity of the arterial chemoreflex with resultant sympathoexcitation in chronic heart failure, resistant hypertension and obstructive sleep apnoea. This observation has led to several successful attempts of removing or denervating the carotid bodies as a therapeutic option in humans. Regrettably, such interventions are accompanied by serious respiratory and acid–base balance side‐effects. Rather than a single stereotyped reaction, arterial chemoreflex comprises an integrative multi‐system response to a variety of stimulants and its specific reflex components may be individually conveyed at varying intensities. Recent research has revealed that carotid bodies express diverse receptors, synthesize a cocktail of mediators, and respond to a plethora of metabolic, hormonal and autonomic nervous stimuli. This state‐of‐the‐art summary discusses exciting new discoveries regarding GLP‐1 receptors, purinergic receptors, the glutamate–GABA system, efferent innervation and regulation of blood flow in the carotid body and how they open new avenues for novel pharmacological treatments selectively targeting specific receptors, mediators and neural pathways to correct distinct responses of the carotid body‐evoked arterial chemoreflex in cardiometabolic diseases. The carotid body offers novel and advantageous therapeutic opportunities for future consideration by trialists. imageKeywords
This publication has 280 references indexed in Scilit:
- Single‐ and Multiple‐Dose Pharmacokinetics of Gefapixant (MK‐7264), a P2X3 Receptor Antagonist, in Healthy AdultsThe Journal of Clinical Pharmacology, 2024
- Transcriptomics of the Carotid Body2023
- Neurochemical plasticity of the carotid body in hypertensionThe Anatomical Record, 2022
- The diversified function and potential therapy of ectopic olfactory receptors in non‐olfactory tissuesJournal of Cellular Physiology, 2017
- Carotid Body Resection for Sympathetic Modulation in Systolic Heart Failure: Results from First-In-Man StudyEuropean Journal of Heart Failure, 2016
- Cardiorespiratory Alterations Induced by Intermittent Hypoxia in a Rat Model of Sleep Apnea2009
- Hypoxia-Inducible Factor (HIF)-1α and Endothelin-1 Expression in the Rat Carotid Body during Intermittent Hypoxia2006
- Hypoxia and electrical stimulation of the carotid sinus nerve induce fos‐like immunoreactivity within catecholaminergic and serotoninergic neurons of the rat brainstemJournal of Comparative Neurology, 1994
- Resection of Carotid Body (Cervical Glomectomy) for AsthmaJAMA, 1962
- Resection of Carotid-Body Jumors with Preservation of the Carotid VesselsArchives of Surgery, 1956